Frequency of Ret mutations in long- and short-segment Hirschsprung disease

Marco Seri, Luo Yin, Virginia Barone, Alessandra Bolino, Iacopo Celli, Renata Bocciardi, Barbara Pasini, Isabella Ceccherini, Margherita Lerone, Ulf Kristoffersson, Lars T. Larsson, Josep Maria Casasa, Daniel T. Cass, Marc Joel Abramowicz, Jean Marie Vanderwinden, Ingrida Kravčenkiene, Ivo Baric, Margherita Silengo, Giuseppe Martucciello, Giovanni Romeo

Research output: Contribution to journalArticle

Abstract

Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long- and short-segment Hirschsprung patients, lead to loss of both transforming and differentiating capacities of the activated RET through a dominant negative effect when expressed in appropriate cellular systems. The approach of single-strand conformational polymorphism analysis established for all the 20 exons of the RET proto-oncogene, and previously used to screen for point mutations in Hirschsprung patients allowed us to identify seven additional mutations among 39 sporadic and familial cases of Hirschsprung disease (detection rate 18%). This relatively low efficiency in detecting mutations of RET in Hirschsprung patients cannot be accounted by the hypothesis of genetic heterogeneity, which is not supported by the results of linkage analysis in the pedigrees analyzed so far. Almost 74% of the point mutations in our series, as well as in other patient series, were identified among long segment patients, who represented only 25% of our patient population. The finding of a C620R substitution in a patient affected with total colonic aganglionosis confirms the involvement of this mutation in the pathogenesis of different phenotypes (i.e., medullary thyroid carcinoma and Hirschsprung). Finally the R313Q mutation identified for the first time in homozygosity in a child born of consanguineous parents is associated with the most severe Hirschsprung phenotype (total colonic aganglionosis with small bowel involvement).

Original languageEnglish
Pages (from-to)243-249
Number of pages7
JournalHuman Mutation
Volume9
Issue number3
DOIs
Publication statusPublished - 1997

Fingerprint

Hirschsprung Disease
Mutation Rate
Mutation
Proto-Oncogenes
Point Mutation
Phenotype
Inborn Genetic Diseases
Genetic Heterogeneity
Neural Crest
Pedigree
Exons
Parents
Newborn Infant
Population

Keywords

  • Hirschsprung disease
  • mutation detection
  • RET proto-oncogene
  • SSCP analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Frequency of Ret mutations in long- and short-segment Hirschsprung disease. / Seri, Marco; Yin, Luo; Barone, Virginia; Bolino, Alessandra; Celli, Iacopo; Bocciardi, Renata; Pasini, Barbara; Ceccherini, Isabella; Lerone, Margherita; Kristoffersson, Ulf; Larsson, Lars T.; Casasa, Josep Maria; Cass, Daniel T.; Abramowicz, Marc Joel; Vanderwinden, Jean Marie; Kravčenkiene, Ingrida; Baric, Ivo; Silengo, Margherita; Martucciello, Giuseppe; Romeo, Giovanni.

In: Human Mutation, Vol. 9, No. 3, 1997, p. 243-249.

Research output: Contribution to journalArticle

Seri, M, Yin, L, Barone, V, Bolino, A, Celli, I, Bocciardi, R, Pasini, B, Ceccherini, I, Lerone, M, Kristoffersson, U, Larsson, LT, Casasa, JM, Cass, DT, Abramowicz, MJ, Vanderwinden, JM, Kravčenkiene, I, Baric, I, Silengo, M, Martucciello, G & Romeo, G 1997, 'Frequency of Ret mutations in long- and short-segment Hirschsprung disease', Human Mutation, vol. 9, no. 3, pp. 243-249. https://doi.org/10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8
Seri, Marco ; Yin, Luo ; Barone, Virginia ; Bolino, Alessandra ; Celli, Iacopo ; Bocciardi, Renata ; Pasini, Barbara ; Ceccherini, Isabella ; Lerone, Margherita ; Kristoffersson, Ulf ; Larsson, Lars T. ; Casasa, Josep Maria ; Cass, Daniel T. ; Abramowicz, Marc Joel ; Vanderwinden, Jean Marie ; Kravčenkiene, Ingrida ; Baric, Ivo ; Silengo, Margherita ; Martucciello, Giuseppe ; Romeo, Giovanni. / Frequency of Ret mutations in long- and short-segment Hirschsprung disease. In: Human Mutation. 1997 ; Vol. 9, No. 3. pp. 243-249.
@article{0b576ff1c75b4b338c01cd9485a340a5,
title = "Frequency of Ret mutations in long- and short-segment Hirschsprung disease",
abstract = "Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long- and short-segment Hirschsprung patients, lead to loss of both transforming and differentiating capacities of the activated RET through a dominant negative effect when expressed in appropriate cellular systems. The approach of single-strand conformational polymorphism analysis established for all the 20 exons of the RET proto-oncogene, and previously used to screen for point mutations in Hirschsprung patients allowed us to identify seven additional mutations among 39 sporadic and familial cases of Hirschsprung disease (detection rate 18{\%}). This relatively low efficiency in detecting mutations of RET in Hirschsprung patients cannot be accounted by the hypothesis of genetic heterogeneity, which is not supported by the results of linkage analysis in the pedigrees analyzed so far. Almost 74{\%} of the point mutations in our series, as well as in other patient series, were identified among long segment patients, who represented only 25{\%} of our patient population. The finding of a C620R substitution in a patient affected with total colonic aganglionosis confirms the involvement of this mutation in the pathogenesis of different phenotypes (i.e., medullary thyroid carcinoma and Hirschsprung). Finally the R313Q mutation identified for the first time in homozygosity in a child born of consanguineous parents is associated with the most severe Hirschsprung phenotype (total colonic aganglionosis with small bowel involvement).",
keywords = "Hirschsprung disease, mutation detection, RET proto-oncogene, SSCP analysis",
author = "Marco Seri and Luo Yin and Virginia Barone and Alessandra Bolino and Iacopo Celli and Renata Bocciardi and Barbara Pasini and Isabella Ceccherini and Margherita Lerone and Ulf Kristoffersson and Larsson, {Lars T.} and Casasa, {Josep Maria} and Cass, {Daniel T.} and Abramowicz, {Marc Joel} and Vanderwinden, {Jean Marie} and Ingrida Kravčenkiene and Ivo Baric and Margherita Silengo and Giuseppe Martucciello and Giovanni Romeo",
year = "1997",
doi = "10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8",
language = "English",
volume = "9",
pages = "243--249",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Frequency of Ret mutations in long- and short-segment Hirschsprung disease

AU - Seri, Marco

AU - Yin, Luo

AU - Barone, Virginia

AU - Bolino, Alessandra

AU - Celli, Iacopo

AU - Bocciardi, Renata

AU - Pasini, Barbara

AU - Ceccherini, Isabella

AU - Lerone, Margherita

AU - Kristoffersson, Ulf

AU - Larsson, Lars T.

AU - Casasa, Josep Maria

AU - Cass, Daniel T.

AU - Abramowicz, Marc Joel

AU - Vanderwinden, Jean Marie

AU - Kravčenkiene, Ingrida

AU - Baric, Ivo

AU - Silengo, Margherita

AU - Martucciello, Giuseppe

AU - Romeo, Giovanni

PY - 1997

Y1 - 1997

N2 - Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long- and short-segment Hirschsprung patients, lead to loss of both transforming and differentiating capacities of the activated RET through a dominant negative effect when expressed in appropriate cellular systems. The approach of single-strand conformational polymorphism analysis established for all the 20 exons of the RET proto-oncogene, and previously used to screen for point mutations in Hirschsprung patients allowed us to identify seven additional mutations among 39 sporadic and familial cases of Hirschsprung disease (detection rate 18%). This relatively low efficiency in detecting mutations of RET in Hirschsprung patients cannot be accounted by the hypothesis of genetic heterogeneity, which is not supported by the results of linkage analysis in the pedigrees analyzed so far. Almost 74% of the point mutations in our series, as well as in other patient series, were identified among long segment patients, who represented only 25% of our patient population. The finding of a C620R substitution in a patient affected with total colonic aganglionosis confirms the involvement of this mutation in the pathogenesis of different phenotypes (i.e., medullary thyroid carcinoma and Hirschsprung). Finally the R313Q mutation identified for the first time in homozygosity in a child born of consanguineous parents is associated with the most severe Hirschsprung phenotype (total colonic aganglionosis with small bowel involvement).

AB - Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long- and short-segment Hirschsprung patients, lead to loss of both transforming and differentiating capacities of the activated RET through a dominant negative effect when expressed in appropriate cellular systems. The approach of single-strand conformational polymorphism analysis established for all the 20 exons of the RET proto-oncogene, and previously used to screen for point mutations in Hirschsprung patients allowed us to identify seven additional mutations among 39 sporadic and familial cases of Hirschsprung disease (detection rate 18%). This relatively low efficiency in detecting mutations of RET in Hirschsprung patients cannot be accounted by the hypothesis of genetic heterogeneity, which is not supported by the results of linkage analysis in the pedigrees analyzed so far. Almost 74% of the point mutations in our series, as well as in other patient series, were identified among long segment patients, who represented only 25% of our patient population. The finding of a C620R substitution in a patient affected with total colonic aganglionosis confirms the involvement of this mutation in the pathogenesis of different phenotypes (i.e., medullary thyroid carcinoma and Hirschsprung). Finally the R313Q mutation identified for the first time in homozygosity in a child born of consanguineous parents is associated with the most severe Hirschsprung phenotype (total colonic aganglionosis with small bowel involvement).

KW - Hirschsprung disease

KW - mutation detection

KW - RET proto-oncogene

KW - SSCP analysis

UR - http://www.scopus.com/inward/record.url?scp=16944365710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16944365710&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8

DO - 10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8

M3 - Article

C2 - 9090527

AN - SCOPUS:16944365710

VL - 9

SP - 243

EP - 249

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -